Different Handling of Beta2-Microglobulin during Hemodialysis and Hemofiltration
Authors:
- J. HagemannJHJ. Hagemann
- D. von HerrathDHD. von Herrath
- K. SchaeferKSK. Schaefer
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 48 (2) , 132-135
Abstract
Very recently it was reported that the amyloid associated with chronic hemodialysis contains, as a major component, a new form of amyloid fibril protein which is homologous to beta 2-microglobulin. As beta 2-microglobulin has a molecular weight of 11,600 daltons, investigations were carried out to see whether or not this protein would be handled differently by hemodialysis and hemofiltration, because the latter method especially is capable of eliminating solutes with such a high molecular weight. The results clearly indicate that hemofiltration removes substantial amounts of beta 2-microglobulin (about 190 mg per treatment, which represents 80% of daily production). It remains to be clarified whether or not hemofiltration is therefore superior to hemodialysis with regard to amyloid deposit formation.Keywords
This publication has 3 references indexed in Scilit:
- β2-microglobulin: A new form of amyloid protein associated with chronic hemodialysisKidney International, 1986
- Peripheral Nerve Entrapment Syndromes in Chronic Hemodialysis PatientsNephron, 1982
- Serum β2-Microglobulin in Hemodialyzed PatientsNephron, 1978